The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Japan's Takeda in regulatory talks to launch dengue vaccine in India
The Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biological E., the companies said earlier in the day. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Zydus aims to launch first new drug in US by early 2026
Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition of CymaBay for $4.3 billion earlier in February. Saroglitazar, currently in a mid-to-late-stage trial for PBC, is also being tested for Metabolic Dysfunction-Associated Steatohepatitis (MASH), a type of fatty liver disease." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

US FDA to boost inspections of drug manufacturing units in India
The FDA plans to increase inspections at Indian drug manufacturing units in 2024. They conducted over 200 inspections in 2023. The Indian pharmaceuticals industry needs to implement good manufacturing practices. Government investment in automation, the drug regulatory body, and drug quality monitoring is necessary. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Will India's pharma sector be able to come out of its China dependence?
Indian pharma industry's heavy dependence on imports for active pharmaceutical ingredients (API), key starting materials (KSM) and basic chemicals has been rather alarming, highlighting the need for a resolution. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Roche Pharma launches multiple sclerosis treatment drug in India
The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Miltenyi Biotec launches India operations, to open Centre in Hyderabad
German biomedical discovery provider Miltenyi Biotec is launching operations in India, opening its first office and setting up a Centre of Excellence. The CoE will offer training in cell and gene therapy and contribute to the vibrant life sciences ecosystem by supporting local development and manufacturing in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025
The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccine
Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda's goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda's existing facility in Germany and its partnership with IDT Biologika GmbH. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 27, 2024 Category: Pharmaceuticals Source Type: news

Pharma companies producing drugs, supplements in same unit under lens
The government, DCGI, and state authorities are cracking down on pharma units manufacturing nutraceuticals, health supplements, and drugs in the same facility. The industry is worried about the impact on exports, domestic market, spurious drugs, and foreign exchange. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2024 Category: Pharmaceuticals Source Type: news

Bristol Myers Squibb opens innovation hub in Hyderabad
Bristol Myers Squibb (BMS) has opened an innovation hub in Hyderabad, India, to expand its global drug development, information technology, and digital capabilities. The facility, expected to house over 1,500 employees, represents an investment of over $100 million. BMS aims to accelerate drug development, enhance digital capabilities, and diversify its global workforce by tapping into local talent in Hyderabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2024 Category: Pharmaceuticals Source Type: news

Mankind counters objections raised by chemists body on supplement ad
Mankind Pharma, ranked as the fourth largest pharmaceutical company in the country, has responded to objections raised by a retail chemists' association regarding its advertisement for the vitamin supplement, HealthOK. The All India Organisation of Chemists and Druggists (AIOCD) had requested the withdrawal of the advertisement, alleging that it implies non-vegetarians are healthier due to its portrayal of actor Ranveer Singh. In a letter dated February 13th, Mankind Pharma addressed the concerns raised by the AIOCD. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2024 Category: Pharmaceuticals Source Type: news

Biocon gets over Rs 3 crore penalty over GST related issues
Biocon said it is "in the process of taking appropriate actions, including but not limited to, filing of the necessary appeal with the appellate authority in this regard". There is no material impact on the financials, operations or other activities of the company, the filing said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2024 Category: Pharmaceuticals Source Type: news

Several small pharma units told to halt operations over quality
The Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a nationwide crackdown on spurious and substandard drugs. Several units in Baddi, Himachal Pradesh, and Punjab have been inspected, with show-cause notices issued and production stopped at some. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

Northeastern India’s first API/Bulk Drug Plant inaugurated in Guwahati
Chemex Global's pharmaceutical API manufacturing facility in Guwahati, first of its kind in the region, positions Assam as the next big pharma hub in India. It aims to expand trade routes with Gujarat, Hyderabad, Sikkim, and Southeast Asia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news

India’s API industry faces high leadership talent churn: Report
Talent churn in manufacturing leadership is currently at about 40% and the trend is expected to continue, given the demand supply gap with the API industry attracting robust investments, the executive search firm said in a report on Thursday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2024 Category: Pharmaceuticals Source Type: news